To understand the mechanism by which CTS treatment reverses diabetes-induced decrease of cholinergic marker proteins in the hippocampus, we immunohistochemically analyzed ChAT-immunopositive neurons in the medial septum that mainly project to the hippocampal area. The gene discussed is CHAT; the disease is diabetes mellitus.